PRECLINICAL AND CLINICAL DEVELOPMENT OF NEURAL STEM CELLS (NSC) DELIVERED AS AN ONCOLYTIC VIROTHERAPY FOR NEWLY DIAGNOSED GLIOMA PATIENTS TO OPTIMIZE TARGETED GLIOMA TREATMENT WITH TUMOR-TROPIC NSCs THAT PRODUCE CONDITIONALLY REPLICATING ONCOLYTIC ADENOVIRUS (CRAd).

PI: Karen S. Aboody, MD
Professor, Department of Developmental & Stem Cell Biology
Scientific Leader, Neuro-Oncology Disease Team
City of Hope NCI Designated Comprehensive Cancer Center & Beckman Research Institute
Duarte, CA

Close Menu